Women with a type of low-risk cancer might not have to rush aggressive treatment, doctors say.
A professor at the University of Illinois is pioneering cancer research that could curb tumor growth. Erik Nelson is an ...
Based on the results of this study, current recommendations suggest that TNBC patients with tumors larger than 2 cm or with ...
Ryne Sandberg made the decision nearly a year ago to go public with his battle with cancer, wanting to keep Cubs fans updated ...
Legendary Cubs second baseman Ryne Sandberg announced on Instagram on Tuesday that his cancer had returned and spread to ...
Some early breast cancer patients can safely avoid specific surgeries, according to two studies exploring ways to lessen ...
A common hair growth drug could help people who are dealing with hair loss during breast cancer treatment, a study has found.
DCIS, known as stage 0 breast cancer, affect the cells lining the milk ducts but has not spread outside the breast.
Patients with low-risk ductal carcinoma in situ (DCIS) who underwent active monitoring reported comparable physical, emotional, and psychological outcomes to patients who received upfront treatment, ...
Bristol Post on MSN1h
'I survived breast cancer but the treatment left me with little-known side effect'A journalist who battled stage three breast cancer has opened up about experiencing a "crash menopause" following her ...
Among patients with hormone receptor (HR)-positive, HER2-negative, low-risk ductal carcinoma in situ (DCIS), those who underwent active monitoring had similar two-year invasive ipsilateral breast ...
A new treatment is showing promise for people with high-risk smoldering multiple myeloma (SMM). This precancerous condition ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback